Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05451628
Other study ID # EC-2021-437
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date March 30, 2022
Est. completion date January 2025

Study information

Verified date December 2023
Source Universitair Ziekenhuis Brussel
Contact Emilie Heuninck
Phone +3224749772
Email emilie.heuninck@uzbrussel.be
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Severe to profound hearing loss affects 0,8% of the global population. For these people, a conventional hearing aid often does not provide sufficient benefit. However, these people can benefit from a cochlear implant (CI). A CI needs to be individually programmed (fitted) for each recipient. A fitting "map" is defined as a set of electrical parameters that are individually adapted to a recipient's needs to achieve optimal sound perception. At present, most CI recipients are fitted with a default frequency allocation map that doesn't take individual variability in size and shape of the cochlea into account. In this study, a fitting strategy based on the post-operative CT scan, that will allow the audiologist to set a frequency-band distribution for CI fitting that may be more closely aligned to the natural tonotopic frequency distribution of a normal hearing cochlea, will be evaluated.


Recruitment information / eligibility

Status Recruiting
Enrollment 40
Est. completion date January 2025
Est. primary completion date January 2025
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Age = 18 years - Post-lingual onset of severe to profound sensory-neural hearing loss in the implanted ear(s) - Post-operative Computed Tomography (CT) scan of the CI electrode available - Pre-operative result of pure-tone audiometry, speech test in quiet and in noise available - Subject implanted with MED-EL cochlear implant(s) - Subjects received a Flex28, FlexSoft or Standard electrode - Subject planned to receive a SONNET 2 or RONDO 3 audio processor on the newly implanted side - Audio processor not yet activated on the newly implanted side - The most apical active electrode contact has to be inserted at least 450° - Minimum of 10 active channels can be activated - Fluent in the language of the test centre - Signed and dated Informed Consent Form (ICF) before the start of any study-specific procedure Exclusion Criteria: - Lack of compliance with any inclusion criteria - Electric Acoustic Stimulation (EAS) user (user of an EAS audio processor) - Implanted with C40+, C40X and C40C - Implanted with an Auditory Brainstem Implant (ABI) or Split electrode array - Anything that, in the opinion of the Investigator, would place the subject at increased risk or pre-clude the subject's full compliance with or completion of the study

Study Design


Intervention

Device:
Default CI fitting
Programming of cochlear implant speech processor according to standard clinical care
Anatomy-based CI fitting
Programming of cochlear implant speech processor with anatomy-based fitting

Locations

Country Name City State
Belgium UZ Brussel Brussel

Sponsors (1)

Lead Sponsor Collaborator
Universitair Ziekenhuis Brussel

Country where clinical trial is conducted

Belgium, 

Outcome

Type Measure Description Time frame Safety issue
Primary Speech recognition test in quiet (S0): percentage correctly identified phonemes 3 months post-activation
Primary Speech recognition test in quiet (S0): percentage correctly identified phonemes 6 months post-activation
Secondary Speech recognition test in noise (S0N0): the speech reception threshold in dB SNR 3 months post-activation
Secondary Speech recognition test in noise (S0N0): the speech reception threshold in dB SNR 6 months post-activation
Secondary Result of the pitch matching test: frequency difference in semitones 3 months post-activation
Secondary Result of the pitch matching test: frequency differences in semitones 6 months post-activation
Secondary Result of the perception of timbre test: Score on Visual Analog Scale (VAS) Patients have to rate the timbre on a visual analog scale (VAS) ranging from 0 to 10, where a higher score reflects a better outcome. 3 months post-activation
Secondary Result of the perception of timbre test: Score on Visual Analog Scale (VAS) Patients have to rate the timbre on a visual analog scale (VAS) ranging from 0 to 10, where a higher score reflects a better outcome. 6 months post-activation
Secondary Result of the consonance and dissonance rating test: Plot of pleasantness over frequency interval and modulation measure 3 months post-activation
Secondary Result of the consonance and dissonance rating test: Plot of pleasantness over frequency interval and modulation measure 6 months post-activation
Secondary Result of the speech contrast discrimination test: Psychometric function of phoneme categorization 3 months post-activation
Secondary Result of the speech contrast discrimination test: Psychometric function of phoneme categorization 6 months post-activation
Secondary Patient reported outcome- Hearing Implant Sound Quality Index (HISQUI): Total score and classification of self-perceived auditory benefit 1 day visit (At the activation of the sound processor)
Secondary Patient reported outcome- Hearing Implant Sound Quality Index (HISQUI): Total score and classification of self-perceived auditory benefit 3 months post-activation
Secondary Patient reported outcome- Hearing Implant Sound Quality Index (HISQUI): Total score and classification of self-perceived auditory benefit 6 months post-activation
Secondary Datalogging data: Average numbers of hours per day 2 weeks post-activation
Secondary Datalogging data: Average numbers of hours per day 1 months post-activation
Secondary Datalogging data: Average numbers of hours per day 3 months post-activation
Secondary Datalogging data: Average numbers of hours per day 6 months post-activation
See also
  Status Clinical Trial Phase
Completed NCT00023036 - Clinical and Genetic Analysis of Enlarged Vestibular Aqueducts
Completed NCT03746613 - Clinal Evaluation of Navigation Based Functional Ear Surgery Using Image Guided and Robotically Assisted Techniques N/A
Recruiting NCT05568329 - Appreciation for Music Processed by Hearing Aids N/A
Withdrawn NCT05061758 - A Trial of LY3056480 in Patients With SNLH Phase 2
Completed NCT01434446 - The Effect of Sound Stimulation on Hearing Ability N/A
Completed NCT03212924 - Listening Effort in Cochlear Implant Users N/A
Recruiting NCT06053190 - Effects of Clear Speech on Listening Effort and Memory in Sentence Processing N/A
Completed NCT03718975 - Quality Control of CE-Certified Phonak Hearing Aids - 2018_28 N/A
Completed NCT06025097 - Intra-Tympanic Steroid With PRP Combination in Sensorineural Hearing Loss and Tinnitus. Early Phase 1
Recruiting NCT04102215 - The Efficacy of a Minimally Invasive Direct Cochlear Access Via the HEARO Procedure N/A
Recruiting NCT04108598 - The SeaSHeL National Prospective Cohort Study
Active, not recruiting NCT04750642 - Cochlear Implant With Dexamethasone Eluting Electrode Array N/A
Completed NCT04120116 - FX-322 in Adults With Stable Sensorineural Hearing Loss Phase 2
Recruiting NCT06223724 - Status Telemetry for Cochlear Implantations
Completed NCT02005822 - Congenital Cytomegalovirus: Efficacy of Antiviral Treatment Phase 3
Suspended NCT02616172 - Autologous Bone Marrow Harvest and Transplant for Sensorineural Hearing Loss Phase 1/Phase 2
Completed NCT02259595 - Study to Determine the Safety, Tolerability, and Pharmacokinetic Profile of HPN-07 and HPN-07 Plus NAC Phase 1
Unknown status NCT01902914 - Effectiveness of P02 Digital Hearing Aids Phase 1/Phase 2
Completed NCT00589511 - Nucleus Freedom Cochlear Implant System Pediatric Post-approval Study N/A
Completed NCT03288753 - Comparison Between Neuro 1 and Neuro 2 Cochlear Implant Speech Processors N/A